Molbio Diagnostics falls 9%: Stock loses 18.5% in 2 days after blockbuster rally Molbio Diagnostics experienced a sharp decline, dropping 8.8% to ₹1,229.65 on September 16, following profit booking after significant gains. Despite the recent downturn, the stock remains over 50% above its IPO price of ₹807, having surged 75% in the last month. eMudhra share price jumps 12% today, extend gains for second session Market prediction: Gift Nifty up; Vaishali Parekh picks three buy or sell Dividend record date: Last chance to buy Asian Energy, Bharat Rasayan, others HDFC Bank stock: Is its low valuation finally a buying opportunity? Jay Thakkar suggests 3 stocks to buy or sell for the short-term in F&O segment How Asian markets, crude will impact Sensex, Nifty? Trade guide for Sensex, Nifty 50, crude oil and gold | Seven stocks to buy Colgate to Rossell Techsys -Sumeet Bagadia gives five breakout shares for Wed Nifty faces risk of retesting June lows on rising US yields and crude oil price Raja Venkatraman recommends two stocks for 16 September

Never say never: Jefferies keeps wealth, asset management entry open Stock recommendations for 16 September from MarketSmith India Brent crude tops $109 as latest attacks threaten key oil shipping routes Oracle shares drop another 3%; key factors behind slump explained US 10-year yield rises to highest since 2007 as Fed rate hike bets strengthen Wall Street drops as oil prices, Treasury yields rise 300% rally in 3 years, multibagger stock to be in focus on Wednesday Vedanta to NMDC | 6 stocks set to benefit from India's critical minerals push Stock Market News Log in to our website to save your bookmarks. It'll just take a moment. Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.